🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improving Outcomes After AF Ablation in Obese Patients

RecruitingNAAges 20 Years - anyAllNational Taiwan University Hospital
NCT07618741 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Improving Outcomes After AF Ablation in Obese Patients

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with Class I indication of catheter ablation of paroxysmal or persistent AF and will undergo catheter ablation at National Taiwan University Hospital. Exclusion Criteria: 1. Informed consent could not be obtained due to personal problem 2. Unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular 3. Current or scheduled enrollment in other conflicting studies, and 4. Concomitant disease or other medical condition likely to result in death within 6 months
💊

What it tests

  • Cardiac Rehabilitation and Lifestyle Modification
  • Usual Care
📍

Where

1 site
National Taiwan University Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy